SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Caroline Le Jeune, Xavier Thomas, Antibody-based therapies in B-cell lineage acute lymphoblastic leukaemia, European Journal of Haematology, 2014, 93, 6
  2. 2
    C. Jacobson, A. LaCasce, How I treat Burkitt lymphoma in adults, Blood, 2014, 124, 19, 2913

    CrossRef

  3. 3
    David A. Rizzieri, Jeffrey L. Johnson, John C. Byrd, Gerard Lozanski, Kristie A. Blum, Bayard L. Powell, Thomas C. Shea, Sreenivasa Nattam, Eva Hoke, Bruce D. Cheson, Richard A. Larson, Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002, British Journal of Haematology, 2014, 165, 1
  4. 4
    Leena V. Maramattom, Parameswaran N. Hari, Linda J. Burns, Jeanette Carreras, William Arcese, Mitchell S. Cairo, Luciano J. Costa, Timothy S. Fenske, Michael Lill, Cesar O. Freytes, Robert Peter Gale, Thomas G. Gross, Gregory A. Hale, Mehdi Hamadani, Leona A. Holmberg, Jack W. Hsu, David J. Inwards, Hillard M. Lazarus, David I. Marks, David G. Maloney, Richard T. Maziarz, Silvia Montoto, David A. Rizzieri, Baldeep Wirk, James L. Gajewski, Autologous and Allogeneic Transplantation for Burkitt Lymphoma Outcomes and Changes in Utilization: A Report from the Center for International Blood and Marrow Transplant Research, Biology of Blood and Marrow Transplantation, 2013, 19, 2, 173

    CrossRef

  5. 5
    Yvette L. Kasamon, Robert A. Brodsky, Michael J. Borowitz, Richard F. Ambinder, Pamela A. Crilley, Steve Y. Cho, Hua-ling Tsai, B. Douglas Smith, Douglas E. Gladstone, Hetty E. Carraway, Carol Ann Huff, William H. Matsui, Javier Bolaños-Meade, Richard J. Jones, Lode J. Swinnen, Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia, Leukemia & Lymphoma, 2013, 54, 3, 483

    CrossRef

  6. 6
    Josep-Maria Ribera, Olga García, Carlos Grande, Jordi Esteve, Albert Oriol, Juan Bergua, José González-Campos, Ferran Vall-llovera, Mar Tormo, Jesús-Maria Hernández-Rivas, Daniel García, Salut Brunet, Natalia Alonso, Pere Barba, Pilar Miralles, Andreu Llorente, Pau Montesinos, Maria-José Moreno, Jose-Ángel Hernández-Rivas, Teresa Bernal, Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status, Cancer, 2013, 119, 9
  7. 7
    S. S. Dave, Genomic stratification for the treatment of lymphomas, Hematology, 2013, 2013, 1, 331

    CrossRef

  8. 8
    S O Ahmed, A Sureda, M Aljurf, The role of hematopoietic SCT in adult Burkitt lymphoma, Bone Marrow Transplantation, 2013, 48, 5, 617

    CrossRef

  9. You have free access to this content9
    David C. Linch, Burkitt lymphoma in adults, British Journal of Haematology, 2012, 156, 6
  10. 10
    Tali Siegal, Neta Goldschmidt, CNS prophylaxis in diffuse large B-cell lymphoma: If, when, how and for whom?, Blood Reviews, 2012, 26, 3, 97

    CrossRef

  11. 11
    Giuseppe Todeschini, Massimiliano Bonifacio, Cristina Tecchio, Rita Balter, Giuseppe Carli, Piero Maria Stefani, Fausto Adami, Alberto Zamò, Angelo Paolo Dei Tos, Filippo Marino, Filippo Gherlinzoni, Pierluigi Marradi, Giampietro Semenzato, Giovanni Pizzolo, Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia, American Journal of Hematology, 2012, 87, 1
  12. 12
    Gaetano Corazzelli, Ferdinando Frigeri, Filippo Russo, Chiara Frairia, Manuela Arcamone, Gennaro Esposito, Annarosaria De Chiara, Emanuela Morelli, Gaetana Capobianco, Cristina Becchimanzi, Francesco Volzone, Mariangela Saggese, Giampaolo Marcacci, Rosaria De Filippi, Umberto Vitolo, Antonio Pinto, RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and ‘unclassifiable’ highly aggressive B-cell lymphoma, British Journal of Haematology, 2012, 156, 2
  13. 13
    Hanny Haaxma-Reiche, Neuro-Oncology Part II, 2012,

    CrossRef

  14. 14
    Deborah A. Thomas, Susan O’Brien, Stefan Faderl, John T. Manning, Jorge Romaguera, Luis Fayad, Fredrick Hagemeister, Jeffrey Medeiros, Jorge Cortes, Hagop Kantarjian, Burkitt Lymphoma and Atypical Burkitt or Burkitt-like Lymphoma: Should These be Treated as Different Diseases?, Current Hematologic Malignancy Reports, 2011, 6, 1, 58

    CrossRef

  15. 15
    Ning-jing Lin, Wen Zheng, Yun-tao Zhang, Xiao-pei Wang, Yu-qin Song, Yan Xie, Mei-feng Tu, Ling-yan Ping, Jun Zhu, Clinical analysis of 13 cases with Burkitt lymphoma or Burkitt-like lymphoma, Clinical Oncology and Cancer Research, 2010, 7, 2, 110

    CrossRef

  16. 16
    Silvia Montoto, Jamie Wilson, Kate Shaw, Maureen Heath, Andy Wilson, Christopher McNamara, Chloe Orkin, Mark Nelson, Margaret Johnson, Mark Bower, and Kate Cwynarski, Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkittʼs lymphoma, AIDS, 2010, 24, 6, 851

    CrossRef

  17. 17
    Rachel J Bishop, Xiaoyan Ding, Charles K Heller, Gabor Illei, Rafael C Caruso, Denise Cunningham, Steven Pavletic, Chi-Chao Chan, RAPID VISION LOSS ASSOCIATED WITH FLUDARABINE ADMINISTRATION, Retina, 2010, 30, 8, 1272

    CrossRef

  18. 18
    G Mead, The Lymphoid Neoplasms 3ed, 2010,

    CrossRef

  19. 19
    Vaishalee P. Kenkre, Wendy Stock, Burkitt Lymphoma/Leukemia: Improving Prognosis, Clinical Lymphoma and Myeloma, 2009, 9, S231

    CrossRef

  20. 20
    Kyung A. Choi, Jung Eun Lee, Yoon-Goo Kim, Dae Joong Kim, Kihyun Kim, Young Hyeh Ko, Ha Young Oh, Won Seog Kim, Wooseong Huh, Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome, Annals of Hematology, 2009, 88, 7, 639

    CrossRef

  21. 21
    Stacey M. Parker, Horatiu Olteanu, Peter VanTuinen, Colleen A. Lawton, Christopher J. Schultz, Kathleen K. Christians, Timothy S. Fenske, Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy, International Journal of Hematology, 2009, 90, 5, 616

    CrossRef

  22. 22
    Deborah A. Thomas, Susan O'Brien, Hagop M. Kantarjian, Monoclonal Antibody Therapy with Rituximab for Acute Lymphoblastic Leukemia, Hematology/Oncology Clinics of North America, 2009, 23, 5, 949

    CrossRef

  23. 23
    Jennifer L. Kelly, Stephen R. Toothaker, Lauren Ciminello, Dieter Hoelzer, Harald Holte, Ann S. LaCasce, Graham Mead, Deborah Thomas, Gustaaf W. Van Imhoff, Brad S. Kahl, Bruce D. Cheson, Ian T. Magrath, Richard I. Fisher, Jonathan W. Friedberg, Outcomes of Patients With Burkitt Lymphoma Older Than Age 40 Treated With Intensive Chemotherapeutic Regimens, Clinical Lymphoma and Myeloma, 2009, 9, 4, 307

    CrossRef

  24. 24
    Ulrich Herrlinger, Michael Glantz, Uwe Schlegel, Christian Gisselbrecht, Franco Cavalli, Should Intra-cerebrospinal Fluid Prophylaxis Be Part of Initial Therapy for Patients With Non-Hodgkin Lymphoma: What We Know, and How We Can Find Out More, Seminars in Oncology, 2009, 36, S25

    CrossRef

  25. 25
    G. M. Mead, S. L. Barrans, W. Qian, J. Walewski, J. A. Radford, M. Wolf, S. M. Clawson, S. P. Stenning, C. L. Yule, A. S. Jack, A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial), Blood, 2008, 112, 6, 2248

    CrossRef

  26. 26
    A. S. Perkins, J. W. Friedberg, Burkitt Lymphoma in Adults, Hematology, 2008, 2008, 1, 341

    CrossRef

  27. 27
    John W. Sweetenham, Highly Aggressive Lymphomas in Adults, Hematology/Oncology Clinics of North America, 2008, 22, 5, 965

    CrossRef

  28. 28
    Matthew J. Matasar, Andrew D. Zelenetz, Overview of Lymphoma Diagnosis and Management, Radiologic Clinics of North America, 2008, 46, 2, 175

    CrossRef

  29. 29
    Sarah Larson, Wendy Stock, Progress in the treatment of adults with acute lymphoblastic leukemia, Current Opinion in Hematology, 2008, 15, 4, 400

    CrossRef

  30. 30
    Victoria S. Blinder, Amy Chadburn, Richard R. Furman, Susan Mathew, John P. Leonard, Review:Improving Outcomes for Patients with Burkitt Lymphoma and HIV, AIDS Patient Care and STDs, 2008, 22, 3, 175

    CrossRef

  31. 31
    Hwee Yong Lim, Eckhard Thiel, Michael J Glantz, To protect and defend: central nervous system prophylaxis in patients with non-Hodgkinʼs lymphoma, Current Opinion in Oncology, 2008, 20, 5, 495

    CrossRef

  32. 32
    Farhad Ravandi, Stefan Faderl, Partow Kebriaei, Hagop Kantarjian, Modern treatment programs for adults with acute lymphoblastic leukemia, Current Hematologic Malignancy Reports, 2007, 2, 3, 169

    CrossRef

  33. 33
    Deborah A. Thomas, Stefan Faderl, Susan O'Brien, Carlos Bueso-Ramos, Jorge Cortes, Guillermo Garcia-Manero, Francis J. Giles, Srdan Verstovsek, William G. Wierda, Sherry A. Pierce, Jianqin Shan, Mark Brandt, Fredrick B. Hagemeister, Michael J. Keating, Fernando Cabanillas, Hagop Kantarjian, Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia, Cancer, 2006, 106, 7
  34. 34
    Quentin A. Hill, Roger G. Owen, CNS prophylaxis in lymphoma: Who to target and what therapy to use, Blood Reviews, 2006, 20, 6, 319

    CrossRef

  35. 35
    John Gerecitano, David J Straus, Treatment of Burkitt lymphoma in adults, Expert Review of Anticancer Therapy, 2006, 6, 3, 373

    CrossRef

  36. 36
    Ian T. Magrath, Treatment of Burkitt lymphoma in children and adults: Lessons from Africa, Current Hematologic Malignancy Reports, 2006, 1, 4, 230

    CrossRef

  37. 37
    Attaya Suvannasankha, Hans Minderman, Kieran L. O'Loughlin, Takeo Nakanishi, Laurie A. Ford, William R. Greco, Meir Wetzler, Douglas D. Ross, Maria R. Baer, Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survival, British Journal of Haematology, 2004, 127, 4
  38. 38
    Current Awareness in Hematological Oncology, Hematological Oncology, 2004, 22, 3
  39. 39
    Yvette L Kasamon, Lode J Swinnen, Treatment advances in adult Burkitt lymphoma and leukemia, Current Opinion in Oncology, 2004, 16, 5, 429

    CrossRef